Dr. Ronald L. Dalman Elected Vice President of SVS

CHICAGO, Illinois, July 18, 2018 – Dr. Ronald L. Dalman was elected vice president of the Society for Vascular Surgery at the organization’s annual meeting in Boston. With his new position, he joins the line of leadership to the presidency.

Previously Dr. Dalman served three years as program chair of the Vascular Annual Meeting and has served on the SVS Board of Directors, the Patient Safety Organization Governing Council, the Education and Research Councils, as well as the PAC Steering, Document Oversight, SVS Foundation Development, Membership, Publications and PSO EVAR Cost Committees.

“I am honored to join the SVS executive team,” Dr. Dalman said. “The Society is the premier organization promoting vascular health worldwide, and has important new directions ahead as it expands its role in several key areas. This is an opportunity to help guide decisions that will impact the profession and the health of patients for years to come.”

Dr. Dalman is board certified in both vascular surgery and surgery, and serves as the Walter C. and Elsa R. Chidester Professor and chief of vascular surgery at Stanford University. Dr. Dalman earned his medical degree at the University of Michigan, and completed surgical and vascular training at the University of Washington (Seattle) and the Oregon Health and Sciences University, respectively. Following training, Dr. Dalman joined the Stanford faculty in 1992 and has directed the vascular program since 2005.

At the Stanford University School of Medicine, Dr. Dalman is a co-director of the Cardiovascular Institute (CVI), currently serving as co-principal investigator of the CVI's NHLBI T32 "Mechanisms and Innovation in Vascular Disease" training grant. Dr. Dalman's research laboratory studies the pathophysiology of abdominal aortic aneurysm (AAA) disease, a leading cause of death in developed and developing countries worldwide, and is actively engaged in identifying and validating new treatment measures for AAA. Dr. Dalman has received continuous research funding from the National Institutes of Health since 1999, and collaborates with leading investigators in AAA disease worldwide.

At Stanford Health Care, Dr. Dalman serves as co-director and quality officer for the Cardiovascular Health Service Line, as well as the medical director of the Vascular Clinic and Non-Invasive Vascular Laboratories. Stanford Vascular Surgery comprises 18 medical and surgical faculty, providing diagnostic and surgical services at eight locations in the Greater San Francisco Bay Area of Northern California.

Dr. Dalman was the 2000 winner of the SVS’s E.J. Wylie Traveling Fellowship in Vascular Surgery, a distinguished guest lecturer in vascular surgery at Harvard Medical School, a presidential guest lecturer/invited speaker of the Asian Vascular Society in 2010 and president of the Western Vascular Society, 2010-11, among many other distinctions.